Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. - PE Ratioverified

PLRX

Price:

$1.16

Market Cap:

$71.83M

Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently progressing through three distinct Phase 2a clinical trials. The company's pipeline also includes PLN-1474, a small-molecule selective inhibitor of avß1, which has successfully completed its Phase 1 clinical assessment for treating liver fibrosis associated with nonalcoholic steatohepatitis...[Read more]

Industry

Biotechnology

IPO Date

2020-06-03

Stock Exchange

NASDAQ

Ticker

PLRX

The PE Ratio as of June 2026 (TTM) for Pliant Therapeutics, Inc. (PLRX) is -0.63

According to Pliant Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.63. This represents a change of -17.54% compared to the average of -0.76 of the last 4 quarters.

Pliant Therapeutics, Inc. (PLRX) Historical PE Ratio (quarterly & annually)

How has PLRX PE Ratio performed in the past?

The mean historical PE Ratio of Pliant Therapeutics, Inc. over the last ten years is 449.09. The current -0.63 PE Ratio has changed -114.03% with respect to the historical average. Over the past ten years (40 quarters), PLRX's PE Ratio was at its highest in in the March 2020 quarter at 10.44. The PE Ratio was at its lowest in in the March 2021 quarter at -15.36.

Quarterly (TTM)
Annual

Average

449.09

Median

-4.98

Minimum

-19.42

Maximum

4.10K

Pliant Therapeutics, Inc. (PLRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pliant Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.30%

Maximum Annual PE Ratio = 4.10K

Minimum Annual Increase = -35292.31%

Minimum Annual PE Ratio = -19.42

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.50-86.77%
2024-3.80-42.37%
2023-6.590.16%
2022-6.5731.98%
2021-4.98-74.35%
2020-19.42-100.47%
20194.10K-35292.31%
2018-11.641.30%

Pliant Therapeutics, Inc. (PLRX) Average PE Ratio

How has PLRX PE Ratio performed in the past?

The current PE Ratio of Pliant Therapeutics, Inc. (PLRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-3.63

5-year avg

-4.49

10-year avg

449.09

Pliant Therapeutics, Inc. (PLRX) PE Ratio vs. Peers

How is PLRX’s PE Ratio compared to its peers?

Pliant Therapeutics, Inc.’s PE Ratio is greater than Zentalis Pharmaceuticals, Inc. (-2.14), less than Sutro Biopharma, Inc. (-0.10), greater than Artiva Biotherapeutics, Inc. (-2.77), less than Adverum Biotechnologies, Inc. (-0.51), greater than Clene Inc. (-1.85), greater than MacroGenics, Inc. (-3.75), greater than Whitehawk Therapeutics Inc (-2.63), greater than Ovid Therapeutics Inc. (-6.56), greater than Coya Therapeutics, Inc. (-4.28), less than Fractyl Health, Inc. Common Stock (-0.49),

Build a custom stock screener for Pliant Therapeutics, Inc. (PLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pliant Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pliant Therapeutics, Inc. (PLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pliant Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pliant Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Pliant Therapeutics, Inc. (PLRX)?

What is the highest PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

What is the 3-year average PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

What is the 5-year average PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

How does the current PE Ratio for Pliant Therapeutics, Inc. (PLRX) compare to its historical average?